Mary Bird Perkins Cancer Center has announced that Victor T. G. Lin, MD, PhD, has joined the organization to oversee its expanded clinical research program and genetic services clinic for patients across the region. Lin was previously an assistant professor at the University of Alabama at Birmingham in the Department of Medicine, Division of Hematology and Oncology.
Through Mary Bird Perkins’ enhanced clinical research program, a greater number of trials are now available to more people. At the same time, the Cancer Center has opened a genetic services clinic, an asset that will help bolster cancer prevention and precision medicine strategies.
Lin’s practice is located in Baton Rouge at 4950 Essen Lane, but patients from across Mary Bird Perkins’ network have access to the clinic’s full range of services. He has also joined Louisiana Hematology Oncology Associates, providing care to patients, particularly with clinical trials and genetics needs.
His major clinical interests include precision oncology and molecularly targeted therapies, thoracic oncology, and sarcoma.
Lin is board-certified in internal medicine, medical oncology, and hematology by the American Board of Internal Medicine. He holds a Bachelor of Science in Biochemistry from Brown University, a PhD in Cellular Biology, and a Doctor of Medicine from the University of Alabama at Birmingham. Lin also completed an internal medicine residency and hematology oncology fellowship at the University of Alabama at Birmingham.
“Joining this high caliber team of medical and radiation oncologists and oncology professionals is an exciting honor,” said Lin. “I look forward to utilizing my academic, scientific, and clinical experience to help enroll more clinical trials participants to advance the field of oncology,” said Lin. “With the world of genetics opening up more than ever, I believe that we will have remarkable opportunities to make major advancements in the early detection and treatment.”
Andrea (Ani) Murphy, FNP-C, ACGN, CGRA, is working closely with Lin in the genetics clinic to provide patients with the highest-quality experience. She is a family nurse practitioner who has completed the City of Hope Intensive Course in Cancer Risk Assessment and is a member of their Clinical Cancer Genomics community of practice. Currently, there are more than 1,000 members across all 50 states and 27 countries. Murphy also has a Cancer Genetic Risk Assessment Certification through the National Consortium of Breast Centers, Inc. and is certified as an advanced clinical genomics nurse through the Nurse Portfolio Credentialing Commission. She was the first nurse practitioner in the state to receive this credential.